571 related articles for article (PubMed ID: 33249439)
1. Multiple Endocrine Neoplasia Type 1: Latest Insights.
Brandi ML; Agarwal SK; Perrier ND; Lines KE; Valk GD; Thakker RV
Endocr Rev; 2021 Mar; 42(2):133-170. PubMed ID: 33249439
[TBL] [Abstract][Full Text] [Related]
2. Review: multiple endocrine neoplasia type 1, sporadic neuroendocrine tumors, and MENIN.
Komminoth P
Diagn Mol Pathol; 1999 Sep; 8(3):107-12. PubMed ID: 10565680
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1.
Marini F; Giusti F; Tonelli F; Brandi ML
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919851
[TBL] [Abstract][Full Text] [Related]
4. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
[TBL] [Abstract][Full Text] [Related]
5. Twenty years of menin: emerging opportunities for restoration of transcriptional regulation in MEN1.
Dreijerink KMA; Timmers HTM; Brown M
Endocr Relat Cancer; 2017 Oct; 24(10):T135-T145. PubMed ID: 28811299
[TBL] [Abstract][Full Text] [Related]
6. The future: genetics advances in MEN1 therapeutic approaches and management strategies.
Agarwal SK
Endocr Relat Cancer; 2017 Oct; 24(10):T119-T134. PubMed ID: 28899949
[TBL] [Abstract][Full Text] [Related]
7. Multiple endocrine neoplasia type 1.
Agarwal SK
Front Horm Res; 2013; 41():1-15. PubMed ID: 23652667
[TBL] [Abstract][Full Text] [Related]
8. Expression and functional analysis of menin in a multiple endocrine neoplasia type 1 (MEN1) patient with somatic loss of heterozygosity in chromosome 11q13 and unidentified germline mutation of the MEN1 gene.
Naito J; Kaji H; Sowa H; Kitazawa R; Kitazawa S; Tsukada T; Hendy GN; Sugimoto T; Chihara K
Endocrine; 2006 Jun; 29(3):485-90. PubMed ID: 16943588
[TBL] [Abstract][Full Text] [Related]
9. The future: medical advances in MEN1 therapeutic approaches and management strategies.
van Leeuwaarde RS; de Laat JM; Pieterman CRC; Dreijerink K; Vriens MR; Valk GD
Endocr Relat Cancer; 2017 Oct; 24(10):T179-T193. PubMed ID: 28768698
[TBL] [Abstract][Full Text] [Related]
10. Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein.
Wautot V; Vercherat C; Lespinasse J; Chambe B; Lenoir GM; Zhang CX; Porchet N; Cordier M; Béroud C; Calender A
Hum Mutat; 2002 Jul; 20(1):35-47. PubMed ID: 12112656
[TBL] [Abstract][Full Text] [Related]
11. Unusual clinical and pathological presentation of a neuroendocrine tumor in a patient with multiple endocrine neoplasia type 1.
Sakurai A; Murakami A; Sano K; Uchino S; Fukushima Y
Endocr J; 2009; 56(7):887-95. PubMed ID: 19564705
[TBL] [Abstract][Full Text] [Related]
12. ARMC5 Alterations in Patients With Sporadic Neuroendocrine Tumors and Multiple Endocrine Neoplasia Type 1 (MEN1).
Damjanovic SS; Antic JA; Elezovic-Kovacevic VI; Dundjerovic DM; Milicevic IT; Beleslin-Cokic BB; Ilic BB; Rodic GS; Berthon A; Maria AG; Faucz FR; Stratakis CA
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4531-42. PubMed ID: 32901291
[TBL] [Abstract][Full Text] [Related]
13. Role of miR-24 in Multiple Endocrine Neoplasia Type 1: A Potential Target for Molecular Therapy.
Marini F; Brandi ML
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298972
[TBL] [Abstract][Full Text] [Related]
14. Multiple endocrine neoplasia type 1 (MEN1).
Thakker RV
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):355-70. PubMed ID: 20833329
[TBL] [Abstract][Full Text] [Related]
15. A Parathyroid-Gut Axis: Hypercalcemia and the Pathogenesis of Gastrinoma in Multiple Endocrine Neoplasia 1.
Hackeng WM; Dreijerink KMA; Offerhaus GJA; Brosens LAA
Mol Cancer Res; 2021 Jun; 19(6):946-949. PubMed ID: 33771883
[TBL] [Abstract][Full Text] [Related]
16. New therapies for patients with multiple endocrine neoplasia type 1.
Geslot A; Vialon M; Caron P; Grunenwald S; Vezzosi D
Ann Endocrinol (Paris); 2021 Apr; 82(2):112-120. PubMed ID: 33839123
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
Dreijerink KM; Höppener JW; Timmers HM; Lips CJ
Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):562-70. PubMed ID: 17024155
[TBL] [Abstract][Full Text] [Related]
18. Multiple Endocrine Neoplasia Type 1: The Potential Role of microRNAs in the Management of the Syndrome.
Donati S; Ciuffi S; Marini F; Palmini G; Miglietta F; Aurilia C; Brandi ML
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066578
[TBL] [Abstract][Full Text] [Related]
19. Menin epigenetically represses Hedgehog signaling in MEN1 tumor syndrome.
Gurung B; Feng Z; Iwamoto DV; Thiel A; Jin G; Fan CM; Ng JM; Curran T; Hua X
Cancer Res; 2013 Apr; 73(8):2650-8. PubMed ID: 23580576
[TBL] [Abstract][Full Text] [Related]
20. Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients.
Marini F; Giusti F; Brandi ML
Orphanet J Rare Dis; 2018 Nov; 13(1):205. PubMed ID: 30428914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
